Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 6 October 2022
Accepted: 5 December 2022
First Online: 10 January 2023
Conflict of interest
: L. Wolff declares that she has no competing interests. M. Raderer received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): Celgene/BMS, Ipsen, Novartis, Roche, Eisai, Eli Lilly. B. Kiesewetter received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): AAA, Boehringer Ingelheim, Ipsen, Novartis, MSD, Eli Lilly, Janssen Cilag.